Journal of Stem Cell Research & Therapy

Unprecedented syndrome of nervous system, bipolar. Clinical advancement in cure using iPSCs cells

7^th International Conference on Stem Cell, Tissue Engineering and Regenerative Medicine

February 27-28, 2025 | Paris, France

Prithiv kumar K R

CEO- Lazer Health Care, USA

Scientific Tracks Abstracts: J Stem Cell Res Ther

Abstract:

Severe illness such as bipolar is most common in developing countries and most population are effected. Stem cell therapy has been a solution to this cognitive or social defect. This chapter is all about balancing and targeting modulation in brain but also regenerating cells. With pathological damage in mental illness, there is novel interference such as modulation of particular cell population. In particular case of damage, oligodendrites played a crucial role. In this chapter, oligodendrites reveal calcium signals in neural cells. The stimulating mechanism of oligodendrites help in proliferation, maturation and myelination response of transplanted cells. The calcium signalling response regulates the neural progenitor cells prolifer ation, migration, differentiation synaptic plasticity which involves neuropsychiatric diseases in human. Protein annotation and protein-protein interaction have been highlighted in this chapter. There are 119 calcium activated proteins in neuropsy chiatry of human brain. The calcium channel stimulating of stem cells zeros on advantage of calcium stimulated stem cells and transplants the signal, to channel the drugs in a devised delivery system. This local delivery guidance of brain delivery method, is visualised using brain imaging technique, providing an unique approach to treatment in psychiatry patients. It was found in our experiments that preconditioning stem cell therapy had high potential during transplantation and advised cared stimulations in procaine shell, synaptic modulation and myelin repair.

Biography :

Dr. Prithiv Kumar K R is the Director and Principal Scientist at Poichyadical Stem Cell Centre for Research and Development (POSCERD), Chicago. He leads cutting-edge research in regenerative medicine and stem cell technologies. Dr. Kumar also serves as the CEO of Laâ??zer Health Care, a premier health innovation company based in Chicago, USA. With extensive exper tise in biomedical sciences, he bridges clinical application and research excellence. His leadership drives global advance ments in healthcare innovation and stem cell therapies.